Apogee Therapeutics Inc (APGE) Com USD0.00001
Sell:$54.00Buy:$83.87
$0.27
(0.35%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Create an alert
Stocks and Shares ISASell:$54.00
Buy:$83.87
Change:$0.27
(0.35%)
$0.27
(0.35%)Prices delayed by at least 15 minutes
Sell:$54.00
Buy:$83.87
Change:$0.27
(0.35%)
$0.27
(0.35%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 10 December 2025 | Michael Thomas HendersonCEO | Sell Regular sell transaction (market) | 9,435 | $74.88 | $706,492.80 | 1,223,552 |
| 10 December 2025 | Michael Thomas HendersonCEO | Sell Regular sell transaction (market) | 10,005 | $75.79 | $758,278.95 | 1,213,547 |
| 10 December 2025 | Michael Thomas HendersonCEO | Sell Regular sell transaction (market) | 560 | $76.58 | $42,884.80 | 1,212,987 |
| 4 December 2025 | Michael Thomas HendersonCEO | Sell Regular sell transaction (market) | 40,000 | $75.01 | $3,000,400.00 | 1,232,987 |
| 4 December 2025 | Carl DambkowskiOther Level A | Sell Regular sell transaction (market) | 10,900 | $75.00 | $817,500.00 | 271,108 |
| 4 December 2025 | Jane Pritchett HendersonCFO | Sell Regular sell transaction (market) | 1,500 | $75.00 | $112,500.00 | 194,871 |
| 25 November 2025 | Jane Pritchett HendersonCFO | Sell Regular sell transaction (market) | 1,500 | $70.00 | $105,000.00 | 196,371 |
| 14 November 2025 | Jane Pritchett HendersonCFO | Sell Regular sell transaction (market) | 2,000 | $65.00 | $130,000.00 | 197,871 |
| 13 November 2025 | Michael Thomas HendersonCEO | Sell Regular sell transaction (market) | 3,340 | $61.93 | $206,846.20 | 1,289,647 |
| 13 November 2025 | Michael Thomas HendersonCEO | Sell Regular sell transaction (market) | 14,774 | $63.14 | $932,830.36 | 1,274,873 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 10 October 2025 | VENROCK HEALTHCARE CAPITAL PARTNERS III LPVenture Capital | Buy Regular purchase transaction | 365,853 | $41.00 | $14,999,936.41 | 365,853 |
| 4 December 2025 | Michael Thomas HendersonCEO | Sell Regular sell transaction (market) | 40,000 | $75.01 | $3,000,400.00 | 1,232,987 |
| 13 November 2025 | Michael Thomas HendersonCEO | Sell Regular sell transaction (market) | 14,774 | $63.14 | $932,830.36 | 1,274,873 |
| 4 December 2025 | Carl DambkowskiOther Level A | Sell Regular sell transaction (market) | 10,900 | $75.00 | $817,500.00 | 271,108 |
| 10 December 2025 | Michael Thomas HendersonCEO | Sell Regular sell transaction (market) | 10,005 | $75.79 | $758,278.95 | 1,213,547 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.